Actualités

Moby summary of Eagle Point Income Company Inc.'s Q2 2026 earnings call

On Aug. 13, 2026, the digital forensics firm reported delays in large transactions and heightened demand for cloud and AI procurement, prompting a leadership change.

Moby summary of Bragg Gaming Group Inc.'s Q2 2026 earnings call

Moby summary of SuperCom Ltd.'s Q2 2026 earnings call

Gossamer Bio (GOSS) delivered earnings and revenue surprises of -100.00% and +171.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Moby summary of Bullish's Q2 2026 earnings call

Moby summary of Birkenstock Holding plc's Q3 2026 earnings call

Moby summary of Beyond Air, Inc.'s Q1 2027 earnings call

Moby summary of Legence Corp. Class A Common stock's Q2 2026 earnings call

Applied Materials posted record third-quarter results and delivered a stronger-than-expected fourth-quarter forecast.

Brookfield (NYSE:BN) reported second-quarter distributable earnings before realizations of $1.4 billion, or $0.61 per share, up 15% per share from a year earlier, as growth in asset management and wealth solutions supported results. Total distributable earnings, including realizations, were $1.5 bi

Bullish (NYSE:BLSH) reported second-quarter results that showed revenue growth and positive adjusted EBITDA despite lower crypto prices and volatility, while executives emphasized tokenized securities and the pending Equiniti acquisition as central to the company’s longer-term strategy. Chief Execu

Sidus Space is set to report its Q2 earnings on Aug. 14. Here’s why investors are cautioned against owning SIDU shares ahead of the earnings event.

Moby summary of Intuitive Machines, Inc.'s Q2 2026 earnings call

Moby summary of American Shared Hospital Services's Q2 2026 earnings call

Moby summary of Aebi Schmidt Holding AG's Q2 2026 earnings call

Applied Materials reports better-than-expected earnings for its fiscal third quarter, but investors aren’t impressed.

Wayfair stock has rebounded over the past few years, yet investors now face a split verdict on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to a large discount while market based multiples suggest the shares are not cheap. Wayfair shareholders have seen the stock decline 63.3% over the past 5 years, which keeps long term returns under pressure even after the more recent recovery. The recent lift in higher end brands and store expansion can support...

Strong AI demand may already be priced in.

Telesat (NASDAQ:TSAT) reported a second-quarter net loss of CAD 559 million as the satellite operator continued to invest in its Lightspeed low Earth orbit network, while its legacy geostationary-orbit business faced ongoing revenue pressure. Chief Financial Officer Donald Tremblay said the quarter

Valneva (NASDAQ:VALN) reported lower first-half revenue and wider losses for 2026, while maintaining its full-year sales outlook and emphasizing its cash position, restructuring measures and expectations for regulatory progress on its Lyme disease vaccine candidate with Pfizer. CEO Thomas Lingelbac

X-Energy (NASDAQ:XE) reported second-quarter 2026 revenue and grant income of $54.6 million, up 154% from a year earlier, as engineering activity increased under the U.S. Department of Energy’s Advanced Reactor Demonstration Program, or ARDP. CEO Clay Sell also said the Department of Energy formall

Coherent recovered from an early decline as accelerating data-center sales and stronger margins reinforced its role in AI connectivity.

Options traders brace for Aug. 20 results.

Cerebras stock crashes after earnings, but Wall Street sees long-term AI upside

Super Micro Computer stock continued its post-earnings rally Thursday while Cisco Systems —another hardware maker that has gotten an artificial-intelligence boost—fell hard. Super Micro stock surged 8% on Thursday to $40.63. Super Micro reported fiscal fourth-quarter financial results after the stock market closed Tuesday.

The space stock's post-earnings pullback isn't too meaningful.

Record backlog and margin expansion signal strong aerospace and defense demand.

Revenue beat forecasts at $215.2 million as power and memory markets show recovery signs.

Gene therapy developer advances three Phase III programs toward 2028 regulatory filings.